<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04062955</url>
  </required_header>
  <id_info>
    <org_study_id>RG1001812</org_study_id>
    <secondary_id>NCI-2019-05132</secondary_id>
    <secondary_id>8665</secondary_id>
    <nct_id>NCT04062955</nct_id>
  </id_info>
  <brief_title>Effects of Alternative Healthy Eating Index-Based Diet on Inflammatory Markers and Breast Density in Healthy Participants</brief_title>
  <official_title>Adherence to the Alternative Healthy Eating Index and Effects on Inflammatory Markers and Breast Density</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fred Hutchinson Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Breast Cancer Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fred Hutchinson Cancer Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial studies the effects of a dietary intervention based on the Alternative Healthy&#xD;
      Eating Index (AHEI) on inflammatory markers and breast density in healthy participants. The&#xD;
      AHEI is a quantifiable measure of diet quality designed to target food and macronutrient&#xD;
      sources that are associated with chronic disease risk. Adherence to the AHEI may be&#xD;
      associated with a reduction in inflammatory biomarkers and sex steroid hormone levels&#xD;
      compared to other dietary patterns/scores.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OUTLINE:&#xD;
&#xD;
      DIETARY INTERVENTION: Participants receive dietary counseling with a dietitian in person or&#xD;
      via telephone to support adherence to a diet based on the AHEI guidelines once weekly for up&#xD;
      to 12 weeks.&#xD;
&#xD;
      DUAL X-RAY ABSORPTIOMETRY (DXA) ONLY STUDY: Participants undergo DXA scan for breast density&#xD;
      measurement at baseline and at 12 weeks.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 28, 2019</start_date>
  <completion_date type="Actual">November 19, 2020</completion_date>
  <primary_completion_date type="Actual">November 19, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in inflammatory markers (IL-6, IL-1β, CRP, sTNFR-1, sTNFR-2, hsCRP)</measure>
    <time_frame>At baseline and week 12</time_frame>
    <description>Levels of IL-6, IL-1β, sTNFR-1, and sTNFR-2 will be measured by immunoassay. hsCRP levels will be measured using a high-sensitivity latex-enhanced immunonephelometric assay on a BNII analyzer.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in breast density</measure>
    <time_frame>At baseline and week 12</time_frame>
    <description>Breast density will be measured by dual x-ray absorptiometry. Depending on the distribution of the data a paired t-test or Wilcoxon signed-rank test will be used.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Healthy Subject</condition>
  <arm_group>
    <arm_group_label>Prevention (dietary intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>DIETARY INTERVENTION: Participants receive dietary counseling with a dietitian in person or via telephone to support adherence to a diet based on the AHEI guidelines once weekly for up to 12 weeks.&#xD;
DXA ONLY STUDY: Participants undergo DXA scan for breast density measurement at baseline and at 12 weeks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Dietary Intervention</intervention_name>
    <description>Receive dietary counseling</description>
    <arm_group_label>Prevention (dietary intervention)</arm_group_label>
    <other_name>Dietary Modification</other_name>
    <other_name>intervention, dietary</other_name>
    <other_name>Nutrition Intervention</other_name>
    <other_name>Nutrition Interventions</other_name>
    <other_name>Nutritional Interventions</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Dual X-ray Absorptiometry</intervention_name>
    <description>Undergo DXA scan</description>
    <arm_group_label>Prevention (dietary intervention)</arm_group_label>
    <other_name>BMD scan</other_name>
    <other_name>bone mineral density scan</other_name>
    <other_name>DEXA</other_name>
    <other_name>DEXA Scan</other_name>
    <other_name>dual energy x-ray absorptiometric scan</other_name>
    <other_name>Dual Energy X-ray Absorptiometry</other_name>
    <other_name>Dual X-Ray Absorptometry</other_name>
    <other_name>DXA</other_name>
    <other_name>DXA SCAN</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Prevention (dietary intervention)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women will be eligible if they are nulliparous, aged 18-30, and score below 75 on the&#xD;
             AHEI. Study eligibility will be assessed via online screening questionnaire and online&#xD;
             Food Frequency Questionnaire (FFQ). These criteria were chosen because of our focus on&#xD;
             the years before first birth as a critical period for establishing breast cancer risk&#xD;
&#xD;
          -  Participants must be able to come to two clinic visits, complete questionnaires in&#xD;
             English, and will be required to discontinue all vitamins and nutritional supplements&#xD;
             during the study period&#xD;
&#xD;
          -  DXA ONLY PILOT STUDY: Participants must be able to come to one visit in the Prevention&#xD;
             Center where they will receive the consent form and undergo the DXA scan. No&#xD;
             intervention will occur and there will be no follow-up assessments or measurements&#xD;
             beyond the DXA scan&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women will be ineligible if they are postmenopausal, pregnant, taking hormone therapy&#xD;
             (e.g., oral contraceptives), or have chronic illnesses that are known to affect&#xD;
             gastrointestinal absorption of nutrients&#xD;
&#xD;
          -  Women who obtain a score of &gt;= 75 on the AHEI are also ineligible&#xD;
&#xD;
          -  DXA ONLY PILOT STUDY: Women who are pregnant&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Holly Harris</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fred Hutch/University of Washington Cancer Consortium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fred Hutch/University of Washington Cancer Consortium</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>August 13, 2019</study_first_submitted>
  <study_first_submitted_qc>August 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2019</study_first_posted>
  <last_update_submitted>January 20, 2021</last_update_submitted>
  <last_update_submitted_qc>January 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast - Female</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

